A drug with the SMILES Cc1c(NC(=O)OCCSc2nc(N(C)C)nc(N(C)C)n2)sc(=S)n1C has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 5.969%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1c(NC(=O)OCCSc2nc(N(C)C)nc(N(C)C)n2)sc(=S)n1C
Cc1c(NC(=O)OCCSc2nc(N(C)C)nc(N(C)C)n2)sc(=S)n1C
2-[[4,6-bis(dimethylamino)-1,3,5-triazin-2-yl]sulfanyl]ethylN-(3,4-dimethyl-2-sulfanylidene-1,3-thiazol-5-yl)carbamate